PT  - JOURNAL ARTICLE
AU  - He, Xiang
AU  - Lin, Bo
AU  - Kong, Lei
AU  - Zhang, Jiawen
TI  - The potential mechanism of chemosensitive difference between 2 types of ovarian cancer
DP  - 2007 Jul 01
TA  - Saudi Medical Journal
PG  - 1044--1049
VI  - 28
IP  - 7
4099  - http://smj.org.sa/content/28/7/1044.short
4100  - http://smj.org.sa/content/28/7/1044.full
SO  - Saudi Med J2007 Jul 01; 28
AB  - OBJECTIVE: To study the potential molecular mechanism of chemosensitive difference between human malignant epithelial and germ cell tumor of the ovary by testing the expression of p53 (mutation), Bcl-2, topoisomerase II alpha (Topo II alpha).METHODS: Immunohistochemical analysis was performed on paraffin embedded tumor tissue microarray from malignant epithelial (n=53) and germ cell tumor of the ovary (n=25) in the Department of Gynecology and Obstetrics, Second West China Hospital of Sichuan University, China from the year 2000 to 2004. The expression of p53, Bcl-2 and Topo II alpha in the 2 types of ovarian cancer was compared and data were analyzed by student t test, Wilcoxon rank sum test and Spearman rank correlation test.RESULTS: The expression of p53 (mutation) in ovarian epithelial cancers (56.6%) was significantly higher than that in the malignant germ cell tumors of the ovary (28%), whereas the expression of Bcl-2 and Topo II alpha had no significant difference between the 2 groups. The expression of p53, Bcl-2 and Topo II alpha had no relationship with the Federation Internationale de Gynecologie Obstetrique (FIGO) stage. The age, FIGO stage and the chemotherapy response were significantly different between the 2 groups.CONCLUSION: The expression of p53 in ovarian cancer was related to chemosensitivity. Our results suggest that p53 may have a role on the difference of chemosensitivity between human malignant epithelial and germ cell tumor of the ovary.